期刊文献+

LC/MS/MS法测定癫痫患儿血浆中拉莫三嗪的浓度 被引量:7

Determination of Plasma Lamotrigine by Liquid Chromatography/Tandem Mass Spectrometry in Children with Epilepsy
下载PDF
导出
摘要 目的建立一种快速、灵敏地测定癫痫患儿血浆中拉莫三嗪(lamotrigine,LTG)的LC/MS/MS方法。方法采用高效液相色谱串联质谱电喷雾检测(LC/MS/MS)法,色谱柱为Welch Materials XB—C18柱,流动相甲醇一水(95:5,V/V,含5mmol/L甲酸铵),流速0.3ml/min,柱温40℃,以碱化的醋酸乙酯:二氯甲烷(4:1)为提取剂。提取的样品经电喷雾离子源正离子化后,通过三重四级杆串联质谱仪,采用选择反应监测(SRM)对LTG(m/z256.0→145.0)和内标阿普唑仑(m/z309.3→281.1)进行测定。结果LTG血药浓度在0.05—25μg/ml范围内线性关系良好(r=0.9989),分析方法的最低检测限为5rig/ml,其高、中、低(12.5、1.25、0.125μg/ml)3个浓度的平均提取回收率分别为82.97%、80.68%和83.33%,日内(n=5)、日间(n=15)RSD均〈15%。结论本方法简单快捷、灵敏、准确、莺现性好。可用于癫痫患儿LTG的临床相药浓序精测和药动学研究. Objective To establish a LC/MS/MS method for determination of plasma concentration of lamotrigine in patients with epilepsy. Method After extracted by acetoacetate and dichlormethane (4: 1, V/V), lamotrigine was analyzed with a LC/MS/MS system using Welch Materials XB-C,s column at a column temperature of 40℃. The mobile phase was consisted of methanol and 5 mmol/L ammonium formate solution (30: 70, V/V), pumped at a flow rate of 0. 3 ml/min. An Agilent 6410 triple quad mass spectrometer system equipped with an electrospray ionization ion-trap source was used as the detector and operated in the positive ion mode. Selection reaction monitoring (SRM) using the precursor to production combinations of m/z 256.0→145.0 and m/z 309.3→281. 1 was performed to detect lamotrigine and alprazolam, respectively. Results The calibration curves of lamotrigine were linear at a concentration range from 0.05 - 25 μg/ml (r =0. 998 9) with both of intra-day and inter-day 〈 15%. The average extraction recoveries were 82.97% ( 12.5 μg/ml) ,80.68% ( 1.25 μg/ml) and 83.33% (0. 125 μg/ml) respectively, with lowest detectable limit of 5 ng/ml. Conclusion The determination of lamotrigine concentrations in plasma is simple, accurate, and reliable. This method is suitable for the blood drug concentration monitoring of lamotrigine and pharmacokinetic study in patients with epilepsy.
出处 《今日药学》 CAS 2011年第3期154-157,共4页 Pharmacy Today
基金 广东省医院药学研究基金(编号:2009B020) 广东省科技计划项目(编号:2009B060700016)
关键词 LC/MS/MS 拉莫三嗪 癫痫 LC/MS/MS lamotrigine epilepsy
  • 相关文献

参考文献7

  • 1陈小陆,任斌,肖力,王振宁,陈洁,冀满丰,李瑞明,陈孝.HPLC测定拉莫三嗪血药浓度[J].中国药学杂志,2008,43(3):232-233. 被引量:14
  • 2杨洁,焦正,施孝金.高效液相色谱法同时测定人血浆中6种抗癫痫药物及两种活性代谢物的浓度[J].中国药学杂志,2006,41(24):1899-1902. 被引量:15
  • 3Stefan h,Feuerstein TJ.Novel anticonvulsant drugs. Pharmacology and Therapeutics . 2007
  • 4Chen C.Validation of a population pharmacokinetic modelfor adjunctive lamotrigine therapy in children. British Journal of Pharmacology . 2000
  • 5Hussein Z,Posner J.Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. British Journal of Clinical Pharmacology . 1997
  • 6Vermeij TA,Edelbroek PM.Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine,oxcarbazepine and zonisamide in serum after solid-phase extraction. Journal of Chromatography B . 2007
  • 7Ogungbenro K,Aarons L.Design of population pharmacokinetic experiments using prior information. Xenobiotica . 2007

二级参考文献9

  • 1宋志彬,廖卫平,易咏红,郑宣,扬春霞,赵绮华,蒲蜀湘.拉莫三嗪在有效血药浓度时对脑电波的影响[J].广州医学院学报,2003,31(4):16-18. 被引量:14
  • 2焦正,钟明康,施孝金,李中东,张静华,王宏图.抗癫癎药物监测[J].中国临床药学杂志,2004,13(6):386-389. 被引量:17
  • 3BUGAMELLI F, SABBIONI C, MANDRIOLI R, et al. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction [J] .Anal Chimica Acta ,2002,472 (1) : 1-10.
  • 4FRANCESCHI L, FURLANUT M. A simple method to monitor plasma concentations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients [J ]. Pharmacol Res, 2005,51 (4).297-302.
  • 5LEVERT H, ODOU P, ROBERT H. LC determination of oxcarbazepine and its active metabolite in human serum[J] .J Pharm Biomed Anal,2002,28 (3-4): 517-525.
  • 6WAD N. Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatography[ J ]. J Chromatogr, 1984,305(1) : 127-133.
  • 7MCDOWALL R D. Sample preparation for biomedical analysis[J] .J Chromatogr, 1989,492:3-58.
  • 8钱方,王玉亮,刘皋林,邓渝林,包军.RP-HPLC法测定拉莫三嗪的血药浓度及应用[J].第二军医大学学报,2000,21(10):998-999. 被引量:6
  • 9欧阳冬生,陈小平,黄松林,余邦宁,谭志荣,周淦,王丹,周宏灏.拉莫三嗪片人体药代动力学和相对生物利用度[J].中国临床药理学杂志,2003,19(4):273-276. 被引量:8

共引文献27

同被引文献51

  • 1焦正,赵志刚,施孝金,钟明康.比较HPLC和FPIA法测定人血清中卡马西平的血药浓度[J].中国临床药理学杂志,2004,20(4):291-294. 被引量:17
  • 2廖卫平,宋志彬,杨少青,蒲蜀湘,易咏红,赵绮华.拉莫三嗪治疗癫癎的有效性与剂量、血药浓度及合并用药关系的研究[J].中国神经精神疾病杂志,2005,31(6):438-441. 被引量:28
  • 3秦炯.小儿癫痫的药物治疗原则[J].中国处方药,2006(7):44-46. 被引量:13
  • 4杨洁,焦正,施孝金.高效液相色谱法同时测定人血浆中6种抗癫痫药物及两种活性代谢物的浓度[J].中国药学杂志,2006,41(24):1899-1902. 被引量:15
  • 5Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: a positionpaper by the subcommission on therapeutic drug monitoring, ILAECommission on Therapeutic Strategies. Epilepsia,2008,49 ( 7 ):1239-1276.
  • 6Sondergaard KM,Nielsen KA,Dahl M,et al. Lamotrigine therapeu-tic thresholds. Seizure,2008,17(5) :391-395.
  • 7Contin M,Balboni M,Callegati E,et al. Simultaneous liquid chro-matographic determination of lamotrigine,oxcarbazepine monohy-droxy derivative and felbamate in plasma of patients with epilepsy.J Chromatogr B Analyt Technol Biomed Life Sci ’ 2005,828 (1-2):113-117.
  • 8Beck 0,Ohman I,Nordgren HK. Determination of lamotrigine andits metabolites in human plasma by liquid chromatography-massspectrometry. Ther Drug Monit, 2006,28(5) :603-607.
  • 9Johannessen SI. Can pharmacokinetic variability be controlled forthe patient's benefit the place of TDM for new AEDs. Ther DrugMonit,2005,27(6) :710-713.
  • 10Yamamoto Y,Inoue Y,Matsuda K,et al. Influence of concomitantantiepileptic drugs on plasma lamotrigine concentration in adultJapanese epilepsy patients. Biol Pharm Bull,2012,35 (4) :487-493.

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部